HomeComparePCDAF vs MRK

PCDAF vs MRK: Dividend Comparison 2026

PCDAF yields 75.47% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PCDAF wins by $1.32M in total portfolio value
10 years
PCDAF
PCDAF
● Live price
75.47%
Share price
$2.65
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.35M
Annual income
$375,142.22
Full PCDAF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — PCDAF vs MRK

📍 PCDAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPCDAFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PCDAF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PCDAF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCDAF
Annual income on $10K today (after 15% tax)
$6,415.09/yr
After 10yr DRIP, annual income (after tax)
$318,870.89/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, PCDAF beats the other by $318,063.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCDAF + MRK for your $10,000?

PCDAF: 50%MRK: 50%
100% MRK50/50100% PCDAF
Portfolio after 10yr
$691.8K
Annual income
$188,046.26/yr
Blended yield
27.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PCDAF
No analyst data
Altman Z
-10.4
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCDAF buys
0
MRK buys
0
No recent congressional trades found for PCDAF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPCDAFMRK
Forward yield75.47%3.25%
Annual dividend / share$2.00$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$1.35M$30.7K
Annual income after 10y$375,142.22$950.29
Total dividends collected$1.17M$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PCDAF vs MRK ($10,000, DRIP)

YearPCDAF PortfolioPCDAF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$18,247$7,547.17$11,192$351.54+$7.1KPCDAF
2$32,395$12,870.51$12,524$392.70+$19.9KPCDAF
3$56,017$21,354.74$14,015$438.65+$42.0KPCDAF
4$94,449$34,510.84$15,682$489.96+$78.8KPCDAF
5$155,442$54,381.15$17,547$547.23+$137.9KPCDAF
6$249,967$83,643.80$19,632$611.16+$230.3KPCDAF
7$393,173$125,708.24$21,963$682.53+$371.2KPCDAF
8$605,486$184,791.09$24,571$762.18+$580.9KPCDAF
9$913,831$265,960.98$27,486$851.08+$886.3KPCDAF
10$1,352,941$375,142.22$30,745$950.29+$1.32MPCDAF

PCDAF vs MRK: Complete Analysis 2026

PCDAFStock

Postmedia Network Canada Corp., through its subsidiary, Postmedia Network Inc., publishes daily and non-daily newspapers in Canada. The company is involved in news and information gathering and dissemination operations through various platforms, such as print, online, and mobile. It also operates digital media and online assets, including newspaper's online website. The company was formerly known as Canwest Limited Partnership and changed its name to Postmedia Network Canada Corp. in July 2010. Postmedia Network Canada Corp. was founded in 2005 and is headquartered in Toronto, Canada.

Full PCDAF Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this PCDAF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCDAF vs SCHDPCDAF vs JEPIPCDAF vs OPCDAF vs KOPCDAF vs MAINPCDAF vs JNJPCDAF vs ABBVPCDAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.